Tectonic Therapeutic, Inc. short interest in 2022
In 2022, Tectonic Therapeutic, Inc.'s disclosed short interest ran from 2.16% of shares outstanding on 14 Jan 2022 to 0.30% on 30 Dec 2022, a change of -1.86 percentage points. The year's high was 4.18% on 31 May 2022 and its low 0.30% on 30 Dec 2022, averaging 1.94% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 5.19 days on 31 May 2022. Full history: Tectonic Therapeutic, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 2.16% (14 Jan 2022)
- End of year
- 0.30% (30 Dec 2022)
- Change
- -1.86 pp
- High
- 4.18% (31 May 2022)
- Low
- 0.30% (30 Dec 2022)
- Average
- 1.94%
- Highest days to cover
- 5.19 (31 May 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 2.16% | 1.00 | |
| 31 Jan 2022 | 2.34% | 1.41 | |
| 15 Feb 2022 | 2.49% | 1.00 | |
| 28 Feb 2022 | 2.76% | 2.70 | |
| 15 Mar 2022 | 2.95% | 5.10 | |
| 31 Mar 2022 | 3.01% | 3.97 | 10-K filed, results (8-K) |
| 14 Apr 2022 | 3.22% | 2.49 | |
| 29 Apr 2022 | 3.83% | 3.32 | |
| 13 May 2022 | 4.02% | 3.87 | 10-Q filed, results (8-K) |
| 31 May 2022 | 4.18% | 5.19 | |
| 15 Jun 2022 | 3.87% | 3.95 | |
| 15 Aug 2022 | 0.69% | 1.41 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 0.59% | 1.39 | |
| 15 Sep 2022 | 0.66% | 2.22 | |
| 30 Sep 2022 | 0.64% | 1.00 | |
| 14 Oct 2022 | 0.65% | 1.00 | |
| 31 Oct 2022 | 0.70% | 1.00 | |
| 15 Nov 2022 | 0.58% | 1.00 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 0.70% | 1.00 | |
| 15 Dec 2022 | 0.47% | 1.00 | |
| 30 Dec 2022 | 0.30% | 1.00 |
See also: Tectonic Therapeutic, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.